Bradykinin Potentiating Peptide 9a (BPP-9a)

BPP-9a is a proline-rich bradykinin-potentiating peptide originally associated with snake venom. Such peptides inhibit angiotensin-converting enzyme and helped establish the pharmacological link between ACE inhibition and blood-pressure control.

• cardiovascular signaling
• GPCR pharmacology
• vascular and inflammatory research
• peptide structure-activity studies

Exact residue boundaries, terminal processing and pyroglutamate formation are integral to peptide identity. Compare only sequence- and modification-matched reagents in quantitative assays.

1. Selected peer-reviewed publication